Opdivo 240 MG/24 ML vial 24ML
Ended Awarded
- Contract number
- SPE2DB25FXN38
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,876
Award facts
- Contract value 100% obligated
- $19,875.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Opdivo 240 mg/24 ml vials, a specialty pharmaceutical product commonly used in oncology treatment. This firm fixed-price delivery order, valued at $19,875.72, is not associated with a set-aside designation and represents a competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of October 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle that runs through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems. The company's extensive contract portfolio with DLA covers a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains, demonstrating its established capability to meet federal medical procurement requirements through open competition. The DLA Troop Support Medical contract enables the company to supply specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FXN38?
SPE2DB25FXN38 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FXN38 worth?
The government has obligated $19,876 on SPE2DB25FXN38.
Is contract SPE2DB25FXN38 an order under another contract?
Yes. SPE2DB25FXN38 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXN38 competed?
The extent of competition for SPE2DB25FXN38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award